article thumbnail

How single-use technologies can improve antibodies production  

Drug Discovery World

The goal of these approaches is to improve process economics by eliminating steps and the amount of reagents, water and buffer. There have been numerous studies that have documented the ability to reduce time and labor, along with reagents and consumables, with single-use technologies compared to its counterpart.

article thumbnail

mRNA Synthesis: ManufacturingProcess of Modern Revolutionary Molecule

Roots Analysis

It transfers genetic information form to DNA to ribosomes, a specialized structure, or organelle, which decodes genetic information into a protein. With the help of genetic engineering, synthetic mRNAs can express proteins, as they structurally resemble a natural mRNA.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The evolution of assays for immuno-oncology research

Drug Discovery World

Genetically engineered mouse models (GEMM) recapitulate the stromal biology of different human cancers including the tumour microenvironment that regulates the disease process. Reagents that can augment and enhance ADCC are of interest in addition to the antibodies themselves. EMBO Mol Med 2017;9:137–53.doi:10.15252/emmm.201606857pmid:[link]

article thumbnail

Overcoming inefficiencies to improve access to cell and gene therapy 

Drug Discovery World

Before 2019, CGT drug developers still had a young, academic mindset, ordering reagents, materials, and equipment haphazardly and assuming they would show up when needed. Genetic Engineering & Biotechnology News. In reality, the situation revealed that, before the pandemic, many in the industry failed to plan well.